North America Lung Transplant Therapeutics Market - Industry Trends and Forecast to 2029

North America lung transplant therapeutics market is projected to register a substantial CAGR of 5.9% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation: 

North America Lung Transplant Therapeutics Market, By Product (Immunosuppressant Drugs, Organ Preservation Products, Tissue Product and Others), Indication (Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis, Septic Lung Disease, Pulmonary Hypertension, Cystic Fibrosis, Interstitial Pulmonary Fibrosis, Emphysema, Sarcoidosis, Primary Pulmonary Arterial Hypertension and Other), Type (Cadaveric Lung Transplantation, Living Lung Transplantation), Technique (Single - Lung Transplantation, Bilateral - Lung Transplantation, Heart - Lung Transplantation, Double - Lung Transplantation), Patient Demographics (Geriatric, Adult, Paediatric), End User (Hospitals, Transplant Centres, Specialty Centres and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the North America lung transplant therapeutics market are: 

• Rising incidence of coronary obstructive pulmonary disorders 

• The rise in technological advancements

Market Players:

The key market players for North America lung transplant therapeutics market are listed below:

• Apotex Inc 
• Bridge to Life Ltd 
• TransMedics (A Subsidiary of TransMedics Group, Inc) 
• Intas Pharmaceuticals Ltd.
• Viatris Inc.
• BioLife Solutions
• Paragonix Technologies, Inc 
• Ose-immuno 
• XVIVO
• 21st Century Medicine 
• Pfizer Inc.
• F.Hoffmann-La Roche Ltd.
• Panacea Biotec Ltd.
• Astellas Pharma Inc.
• Accord-UK Ltd
• Novartis AG 
• Hikma Pharmaceuticals PLC 
• Dr. Franz Köhler Chemie GmbH
• Detraxi Inc
• Dr. Reddy’s Laboratories Ltd. 
• bioMérieux SA
• Pacific Biosciences of California, Inc. 
• GENEWIZ
• 10x Genomics
• New England Biolabs
• Hamilton Company